Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3397454
Max Phase: Preclinical
Molecular Formula: C26H24F3N3O5S2
Molecular Weight: 579.62
Molecule Type: Small molecule
Associated Items:
ID: ALA3397454
Max Phase: Preclinical
Molecular Formula: C26H24F3N3O5S2
Molecular Weight: 579.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c(cc1S(=O)(=O)N1CCN(c3ccc(C(F)(F)F)cc3)CC1)N(CC(=O)c1cccs1)C(=O)CO2
Standard InChI: InChI=1S/C26H24F3N3O5S2/c1-17-13-22-20(32(25(34)16-37-22)15-21(33)23-3-2-12-38-23)14-24(17)39(35,36)31-10-8-30(9-11-31)19-6-4-18(5-7-19)26(27,28)29/h2-7,12-14H,8-11,15-16H2,1H3
Standard InChI Key: QGANXHRUHTVDKA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 579.62 | Molecular Weight (Monoisotopic): 579.1109 | AlogP: 4.19 | #Rotatable Bonds: 6 |
Polar Surface Area: 87.23 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 1.90 | CX LogP: 3.95 | CX LogD: 3.95 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.41 | Np Likeness Score: -2.09 |
1. Konda S, Raparthi S, Bhaskar K, Munaganti RK, Guguloth V, Nagarapu L, Akkewar DM.. (2015) Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives., 25 (7): [PMID:25754493] [10.1016/j.bmcl.2015.01.026] |
Source(1):